Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
The Journal of Clinical Psychiatry
|
June 7, 2018
A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder
Mary Hobart, Aleksandar Skuban, Peter Zhang, et al.
The American Journal of Psychiatry
|
April 3, 2008
Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study
Eduard Vieta, Caroline T'joen, Robert D McQuade, et al.
Schizophrenia Research
|
July 30, 2013
Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: an open-label, parallel-arm, multiple-dose study
Suresh Mallikaarjun, John M Kane, Patricia Bricmont, et al.
Bipolar Disorders
|
February 15, 2012
Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)
Berit X Carlson, Terence A Ketter, Wei Sun, et al.
Current Medical Research and Opinion
|
January 19, 2018
Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study
Mary Hobart, Aleksandar Skuban, Peter Zhang, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
September 2, 2005
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial
Eduard Vieta, Michel Bourin, Raymond Sanchez, et al.
Journal of Pain and Symptom Management
|
September 20, 2017
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain
Aron H Lichtman, Eberhard Albert Lux, Robert McQuade, et al.
Substance Use & Addiction Journal
|
March 5, 2026
Cultivating Leaders in the Addiction Behavioral Health Workforce: New England Addiction Technology Transfer Center's Leadership Development Program
Sara J Becker, Madeleine Kemo, Amelia Bailey, et al.
CNS Spectrums
|
August 18, 2016
Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics
Timothy Peters-Strickland, Cathy Zhao, Pamela P Perry, et al.
British Journal of Pain
|
August 9, 2017
Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies
Marie T Fallon, Eberhard Albert Lux, Robert McQuade, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
The Journal of Clinical Psychiatry
|
June 7, 2018
A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder
Mary Hobart, Aleksandar Skuban, Peter Zhang, et al.
The American Journal of Psychiatry
|
April 3, 2008
Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study
Eduard Vieta, Caroline T'joen, Robert D McQuade, et al.
Schizophrenia Research
|
July 30, 2013
Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: an open-label, parallel-arm, multiple-dose study
Suresh Mallikaarjun, John M Kane, Patricia Bricmont, et al.
Bipolar Disorders
|
February 15, 2012
Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)
Berit X Carlson, Terence A Ketter, Wei Sun, et al.
Current Medical Research and Opinion
|
January 19, 2018
Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study
Mary Hobart, Aleksandar Skuban, Peter Zhang, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
September 2, 2005
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial
Eduard Vieta, Michel Bourin, Raymond Sanchez, et al.
Journal of Pain and Symptom Management
|
September 20, 2017
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain
Aron H Lichtman, Eberhard Albert Lux, Robert McQuade, et al.
Substance Use & Addiction Journal
|
March 5, 2026
Cultivating Leaders in the Addiction Behavioral Health Workforce: New England Addiction Technology Transfer Center's Leadership Development Program
Sara J Becker, Madeleine Kemo, Amelia Bailey, et al.
CNS Spectrums
|
August 18, 2016
Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics
Timothy Peters-Strickland, Cathy Zhao, Pamela P Perry, et al.
British Journal of Pain
|
August 9, 2017
Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies
Marie T Fallon, Eberhard Albert Lux, Robert McQuade, et al.
Page
of 6